U.S. Rep. Frank Pallone Jr., D-N.J., introduced bipartisan legislation this week that would allow designated universities, including Rutgers, to partner with the Food and Drug Administration and industry to further develop and implement a faster, more efficient pharmaceutical manufacturing process. Learn more.
Recent Posts
- NJACTS Community Engagement Core Available Services
- Join NJ ACTS for a Seminar on Clinical Research Record Retention on 3/2 at 12
- CTSA Translational Impact Summit on March 2&3 (Virtual) – Register Now!
- Join NJ ACTS for Boosted: The Impact of Science, Society, and Policy on Public Health on 2/27 at 12
- NJACTS Community Engagement Core COVID-19 Resources
Categories
- Community (2,440)
- Covid (997)
- CTO Events (6)
- News (3,092)
- Pilots (21)